VIDEO: Genetic test helps identify patients with breast cancer who may avoid chemotherapy

CHICAGO — In this video, Shimoli Barot, MD, discusses a study that showed a genomic test could be used to identify patients with clinically high-risk ER-positive, HER2-negative breast cancer who may be able to safely avoid chemotherapy.These findings, from the phase 3 OPTIMA trial, were presented at ASCO Annual Meeting.